All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Alzheimer's Research Impact: Uncovering a 16-Year Setback

By

walterbell

11mo ago· 4 min readenNews

Summary

A landmark study in Nature that identified a possible cause of Alzheimer’s disease in 2006 influenced research for almost 16 years until concerns of image manipulation were raised in 2022, setting back treatment progress.

Key quotes

· 2 pulled
"There was concern regarding the images that accompanied the article."
"A whistleblower had come forward and said the images appeared to have been manipulated."
Snippet from the RSS feed
What is the Alzheimer's research scandal? Learn what neuroscientist Matthew Schrag has to say about possible fraudulent Alzheimer's research from a 2006 study.

You might also wanna read

Woman develops whiplike rash on back after eating shiitake mushrooms

A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas

livescience.com·50m ago

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins

pasadenastarnews.com·3h ago

Molecular glue approach doubles survival time for aggressive pancreatic cancer patients

Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins

pasadenastarnews.com·4h ago

Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds

An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug works b

bit.ly·4h ago

Senolytic treatment linked to oligodendrocyte dysfunction and demyelination in brain study

This scientific research article investigates the effects of senolytic treatment (dasatinib and quercetin combination) on the corpus callosu

pnas.org·4h ago

Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds

Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a

npr.org·5h ago